<?xml version="1.0" encoding="UTF-8"?>
<p>Primary antibodies used in our study are as follows: mouse monoclonal antibody against GAPDH (60004-1-lg, Proteintech, Rosemont, IL, USA), rabbit polyclonal antibody against GAPDH (10494-1-AP, Proteintech), mouse monoclonal antibody against beta-actin (sc47778, Santa Cruz Biotechnology, Dallas, TX, USA), rabbit monoclonal antibody against METTL3 (15073-1-AP, Proteintech), anti-METTL14 (SAB1104405, Sigma-Aldrich), anti-WTAP (ab155655, Abcam, Cambridge, UK), anti-ALKBH5 (ab69325, Abcam), anti-FTO (ab124892, Abcam), anti-YTHDF1 (17479-1-AP, Proteintech), anti-YTHDF2 (24744-1-AP, Proteintech), anti-YTHDF3 (25537-1-AP, Proteintech), anti-YTHDC1 (14392-1-AP, Proteintech), anti-Histone 3 (GTX122148, GeneTex), anti-Flag (F1804-1 MG, Sigma-Aldrich), anti-HA (66006-1-Ig, Proteintech)Â and a mouse polyclonal antibody against EV71 VP1 generated in house. The secondary antibodies used in the study are goat anti-mouse IgG and goat anti-rabbit IgG were supplied by AntiGene Biotech GmbH, Stuttgart, Germany. Alexa Fluor 488, Alexa Fluor 568-conjugated secondary antibodies, and Hoechst 33258 were purchased from Invitrogen.</p>
